San Diego-dependent Viking Therapeutics marked itself as a serious competitor inside the weight loss drug industry in February after revealing promising info from the mid-stage trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when specified as a weekly injection As well as in March the company u